SP Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,700
Closed -$232K 138
2026
Q1
$232K Sell
3,700
-292
-7% -$23.4K 0.02% 113
2025
Q4
$381K Hold
3,992
0.03% 101
2025
Q3
$390K Hold
3,992
0.03% 100
2025
Q2
$429K Hold
3,992
0.04% 97
2025
Q1
$403K Hold
3,992
0.04% 94
2024
Q4
$357K Hold
3,992
0.03% 98
2024
Q3
$335K Sell
3,992
-72
-2% -$5.68K 0.03% 100
2024
Q2
$313K Buy
4,064
+292
+8% +$21.4K 0.03% 105
2024
Q1
$258K Hold
3,772
0.02% 107
2023
Q4
$218K Buy
+3,772
New +$201K 0.02% 110
2023
Q3
Sell
-3,772
Closed -$204K 115
2023
Q2
$204K Buy
+3,772
New +$197K 0.02% 109

Other funds holding BSX

SP Asset Management's BSX Position: Q2 2026 in Review

SP Asset Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,700 shares — an estimated $232K sold.

SP Asset Management first reported a position in BSX in Q2 2023 and held it in 11 quarters. The position peaked at $429K in Q2 2025. 614 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • SP Asset Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • SP Asset Management sold 3,700 Boston Scientific shares in Q2 2026, an estimated $232K.
  • SP Asset Management first reported a position in Boston Scientific in Q2 2023 and held it in 11 quarters.
  • SP Asset Management's Boston Scientific position peaked at $429K in Q2 2025.
  • 614 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on SP Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.